The surgical technology developer was valued at $3bn in a series C round co-led by SoftBank Vision Fund 2 and backed by Tencent and GE Healthcare.

Internet and telecommunications group SoftBank’s Vision Fund 2 co-led a $600m series D round for UK-headquartered surgical robotics technology developer CMR Surgical today with healthcare investment group Ally Bridge.

GE Healthcare, a subsidiary of power and industrial technology conglomerate General Electric, also took part in the round, which valued the company at $3bn, as did internet group Tencent.

RPMI Railpen and Chimera filled out the consortium together with existing backers including LGT and its Lightrock affiliate, Watrium, Cambridge Innovation Capital…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.
Email LinkedIn